Join to View Full Profile
9000 Rockville PikeBldg 10Bethesda, MD 20892
Phone+1 301-496-4000
Dr. Lisco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andrea Lisco is an infectious disease specialist in Bethesda, MD and is affiliated with NIH Clinical Center. He received his medical degree from University of Bari Faculty of Medicine and has been in practice 17 years. He specializes in Hiv/Aids medicine and clinical immunology. He has more than 90 publications and over 2000 citations.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2014 - 2016
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Bari Faculty of MedicineClass of 2000
Certifications & Licensure
DC State Medical License 2014 - 2027
OH State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia Start of enrollment: 2019 Feb 04
- A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia Start of enrollment: 2024 Nov 06
- Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) Start of enrollment: 2021 Nov 17
Publications & Presentations
PubMed
- Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor Signaling.Peiying Ye, Jenna R E Bergerson, Isaac Brownell, Gabriel J Starrett, Roshini S Abraham
The New England Journal of Medicine. 2025-07-31 - Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival.Morgan N Similuk, Sarah A Bannon, Jia Yan, Rajarshi Ghosh, Ekaterina E Damskey
Transplantation. 2025-07-31 - Impact of Anti-CD4 Autoantibodies on Immune Reconstitution in People With Advanced HIV.Brian P Epling, Andrea Lisco, Maura Manion, Elizabeth Laidlaw, Frances Galindo
Clinical Infectious Diseases. 2025-07-18
Press Mentions
Oral Sex Could Increase Your Risk of SKIN Cancer – the 3 Ways to Protect YourselfAugust 7th, 2025- S£Xually Transmitted Disease Spread by Kissing and Oral s£X Linked to skin CancerAugust 7th, 2025
- “Benign” HPV Strains Can Cause Skin Cancer in Immunodeficient IndividualsJuly 31st, 2025
- Join now to see all
Grant Support
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
